Pharmacists' experiences with dispensing opioids: provincial survey.

OBJECTIVE To explore pharmacists' beliefs, practices, and experiences regarding opioid dispensing. DESIGN Mailed survey. SETTING The province of Ontario. PARTICIPANTS A total of 1011 pharmacists selected from the Ontario College of Pharmacists' registration list. MAIN OUTCOME MEASURES Pharmacists' experiences with opioid-related adverse events (intoxication and aberrant drug-related behaviour) and their interactions with physicians. RESULTS A total of 652 pharmacists returned the survey, for a response rate of 64%. Most (86%) reported that they were concerned about several or many of their patients who were taking opioids; 36% reported that at least 1 patient was intoxicated from opioids while visiting their pharmacies within the past year. Reasons for opioid intoxication included the patient taking more than prescribed (84%), the patient using alcohol or sedating drugs along with the opioid (69.9%), or the prescribed dose being too high (34%). Participants' most common concerns in the 3 months before the survey were patients coming in early for prescription refills, suspected double-doctoring, and requests for replacement doses for lost medication (reported frequently by 39%, 12%, and 16% of respondents, respectively). Pharmacists were concerned about physician practices, such as prescribing benzodiazepines along with opioids. Pharmacists reported difficulty in reaching physicians directly by telephone (43%), and indicated that physicians frequently did not return their calls promptly (28%). The strategies rated as most helpful for improving opioid dispensing were a provincial prescription database and opioid prescribing guidelines. CONCLUSION Pharmacists commonly observe opioid intoxication and aberrant drug-related behaviour in their patients but have difficulty communicating their concerns to physicians. System-wide strategies are urgently needed to improve the safety of opioid prescribing and to enhance communication between physicians and pharmacists.

[1]  M. Kahan,et al.  Survey of Ontario primary care physicians' experiences with opioid prescribing. , 2011, Canadian family physician Medecin de famille canadien.

[2]  P. Chisnall.  Mail and Internet Surveys: The Tailored Design Method , 2007, Journal of Advertising Research.

[3]  C. Bond,et al.  Attitudinal factors associated with community pharmacists' involvement in services for drug misusers. , 1999, Addiction.

[4]  D. Dillman.  Mail and internet surveys: The tailored design method, 2nd ed. , 2007 .

[5]  D. Juurlink,et al.  Prescribing of opioid analgesics and related mortality before and after the introduction of long-acting oxycodone , 2009, Canadian Medical Association Journal.

[6]  Beth Sproule,et al.  Changing patterns in opioid addiction: characterizing users of oxycodone and other opioids. , 2009, Canadian family physician Medecin de famille canadien.

[7]  W. Ling,et al.  Pharmacists' and technicians' perceptions and attitudes toward dispensing buprenorphine/ naloxone to patients with opioid dependence. , 2005, Journal of the American Pharmacists Association : JAPhA.

[8]  A. Gilson,et al.  Pharmacists' Knowledge of and Attitudes toward Opioid Pain Medications in Relation to Federal and State Policies , 2022 .

[9]  Siobhan McCann,et al.  Perceived interprofessional barriers between community pharmacists and general practitioners: a qualitative assessment. , 2003, The British journal of general practice : the journal of the Royal College of General Practitioners.

[10]  J. Bouchez,et al.  The French Experience – the Pharmacist, General Practitioner and Patient Perspective , 1998, European Addiction Research.